Overview
Hailey-Hailey disease, also known as familial benign chronic pemphigus or benign familial pemphigus, is a rare genetic skin disorder caused by mutations in the ATP2C1 gene, which encodes a calcium pump essential for proper cell-to-cell adhesion in the epidermis. The defective calcium signaling leads to impaired formation of desmosomes, the structures that hold skin cells (keratinocytes) together, resulting in acantholysis — the loss of cohesion between skin cells. The disease primarily affects the skin, with recurrent episodes of blistering, erosions, and maceration occurring predominantly in intertriginous areas (skin folds) such as the groin, axillae (armpits), neck, and under the breasts. Lesions often present as painful, erythematous, crusted, and sometimes malodorous plaques that can significantly impair quality of life. Flare-ups are commonly triggered by friction, heat, sweating, secondary bacterial or fungal infections, and ultraviolet light exposure. Symptoms typically first appear in the second to fourth decade of life, though onset can vary. Longitudinal white bands on the fingernails (longitudinal leukonychia) may also be observed. There is currently no cure for Hailey-Hailey disease. Treatment is primarily aimed at managing symptoms and preventing flares. First-line approaches include topical corticosteroids, topical antibiotics, and antifungal agents to control secondary infections. For more severe or refractory cases, systemic treatments such as oral antibiotics, dapsone, or retinoids may be used. Procedural interventions including carbon dioxide laser ablation, botulinum toxin injections (to reduce sweating), photodynamic therapy, and surgical excision of affected areas have shown benefit in selected patients. General measures such as wearing loose-fitting clothing, minimizing friction, and keeping skin folds dry are important adjunctive strategies.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
1 eventYale University — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Hailey-Hailey disease.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hailey-Hailey disease.
Community
No community posts yet. Be the first to share your experience with Hailey-Hailey disease.
Start the conversation →Latest news about Hailey-Hailey disease
Disease timeline:
New recruiting trial: Efficacy of Guselkumab in Treating Hailey Hailey Disease
A new clinical trial is recruiting patients for Hailey-Hailey disease
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hailey-Hailey disease
What is Hailey-Hailey disease?
Hailey-Hailey disease, also known as familial benign chronic pemphigus or benign familial pemphigus, is a rare genetic skin disorder caused by mutations in the ATP2C1 gene, which encodes a calcium pump essential for proper cell-to-cell adhesion in the epidermis. The defective calcium signaling leads to impaired formation of desmosomes, the structures that hold skin cells (keratinocytes) together, resulting in acantholysis — the loss of cohesion between skin cells. The disease primarily affects the skin, with recurrent episodes of blistering, erosions, and maceration occurring predominantly in
How is Hailey-Hailey disease inherited?
Hailey-Hailey disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hailey-Hailey disease typically begin?
Typical onset of Hailey-Hailey disease is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Hailey-Hailey disease?
Yes — 1 recruiting clinical trial is currently listed for Hailey-Hailey disease on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Hailey-Hailey disease?
19 specialists and care centers treating Hailey-Hailey disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.